Table 1.
Patient Characteristics. For Background parenchymal enhancement (BPE) and fibroglandular tissue (FGT), results are reported for each of two readers (R1 and R2).
| Patient Group | Total Number |
|---|---|
| Patients | 27 |
| Age (range) | 53 (33-80) |
| Menopausal status | |
| Post | 14 (51.9%) |
| Pre | 13 (48.1%) |
| Background Parenchymal Enhancement on MRI | |
| Minimal | 6 (22.2%) R1, 8 (29.6%) R2 |
| Mild | 14 (51.9%) R1, 12 (44.4%) R2 |
| Moderate | 6 (22.2%) R1,6 (22.2%) R2 |
| Marked | 1 (3.7%) R1, 1 (3.7%) R2 |
| Fibroglandular Tissue on MRI | |
| Almost Entirely Fatty | 6 (22.2%) R1, 5 (18.5%) R2 |
| Scattered Fibroglandular Tissue | 8 (29.6%) R1, 8(29.6%) R2 |
| Heterogeneous Fibroglandular Tissue | 7 (25.9%) R1, 8(29.6%) R2 |
| Extreme Fibroglandular Tissue | 6 (22.2%) R1,6 (22.2%) R2 |
| Breast Cancer Size | |
| 2 - 4 cm | 24 (88.9%) |
| > 4 cm | 3 (11.1%) |
| Histopathology | |
| Invasive Ductal Cancer | 24 (88.9%) |
| Invasive Lobular Cancer | 1 (3.7%) |
| Invasive Mammary Cancer | 2 (7.4%) |